0001209191-19-017201.txt : 20190305 0001209191-19-017201.hdr.sgml : 20190305 20190305210129 ACCESSION NUMBER: 0001209191-19-017201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190305 DATE AS OF CHANGE: 20190305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dispersyn Gerrit CENTRAL INDEX KEY: 0001704417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 19661010 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-01 0 0001533040 Phio Pharmaceuticals Corp. PHIO 0001704417 Dispersyn Gerrit C/O PHIO PHARMACEUTICALS CORP. 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 0 1 0 0 President & CEO Common Stock 2019-03-01 4 A 0 407703 0.00 A 479053 D As reported on the Current Report on Form 8-K filed on February 15, 2019 and pursuant to the reporting person's appointment as CEO, the securities reported represent shares underlying a restricted stock unit, of which shares will vest in four equal annual installments. Additionally, the reporting person's right to receive the underlying shares at vesting is subject to stockholder approval of an increase in the authorized shares under the Company's equity compensation plan. In the event that such an increase is not approved, then no shares will be issued at the applicable vesting date. Caitlin Kontulis, attorney-in-fact 2019-03-05